Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota
Ruiting Han, Huihui Qiu, Jing Zhong, et al.
Phytomedicine (2021) Vol. 85, pp. 153544-153544
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy
Li-Ran Zhu, Shanshan Li, Wan-Qun Zheng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
The interplay between herbal medicines and gut microbiota in metabolic diseases
Lijie Wang, Xiaoling Gou, Yin Ding, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 30
Zanthoxylum bungeanum amides ameliorates nonalcoholic fatty liver via regulating gut microbiota and activating AMPK/Nrf2 signaling
Wei Peng, Cheng-Xun He, Ruolan Li, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116848-116848
Closed Access | Times Cited: 30
Health and Disease: Akkermansia muciniphila , the Shining Star of the Gut Flora
Chen Xue, Ganglei Li, Xinyu Gu, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 21
Integrated traditional Chinese and Western medicine in the prevention and treatment of non-alcoholic fatty liver disease: future directions and strategies
Xin Ding, Xu He, Bulang Tang, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
Longshan Ji, Qian Li, Yong He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3529-3547
Open Access | Times Cited: 27
Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites
Mingzhe Zhu, Xue Wang, Kai Wang, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 19
Traditional Chinese medicine for the treatment of chronic inflammatory diseases: A review of inhibitors for NLRP3 inflammasome
Yucen Zou, Pei Ma, Bin Li, et al.
Advanced Chinese Medicine (2025)
Open Access
Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives
Yuqiu Han, Lanjuan Li, Baohong Wang
Frontiers of Medicine (2022) Vol. 16, Iss. 5, pp. 667-685
Closed Access | Times Cited: 26
Intestine‐Targeted Explosive Hydrogel Microsphere Promotes Uric Acid Excretion for Gout Therapy
Yunkai Tang, Yawei Du, Junna Ye, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 15
Biotransformed bear bile powder ameliorates diet-induced nonalcoholic steatohepatitis in mice through modulating arginine biosynthesis via FXR/PXR-PI3K-AKT-NOS3 axis
Shan Jiang, Xiaolu Wei, Yan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115640-115640
Open Access | Times Cited: 14
Gut-immunity-joint axis: a new therapeutic target for gouty arthritis
Pei‐Jer Chen, Zhiqiang Luo, Chengyin Lu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Global research trends in Chinese medicine for the treatment of non-alcoholic fatty liver disease (NAFLD): a bibliometric study
Kangjie li, Jie Wang, Ming Dang, et al.
Pharmacological Research - Modern Chinese Medicine (2025), pp. 100585-100585
Open Access
Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids
Yan Li, Jindong Zhao
Frontiers in Microbiology (2025) Vol. 16
Open Access
Research Progress of Non-Alcoholic Fatty Liver Disease from the Perspective of Intestinal Flora
雪 罗
Advances in Clinical Medicine (2025) Vol. 15, Iss. 03, pp. 477-490
Closed Access
Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases
Sathish Kumar Perumal, Madan Kumar Arumugam, Natalia A. Osna, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Xihuang Pill enhances anticancer effect of anlotinib by regulating gut microbiota composition and tumor angiogenesis pathway
Bo Cao, Shiyuan Wang, Ruisheng Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113081-113081
Open Access | Times Cited: 19
Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1
Zhi Shang, Yating Gao, Yan Xue, et al.
Phytomedicine (2023) Vol. 123, pp. 155183-155183
Closed Access | Times Cited: 12
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders
Min Liu, Wei Shi, Yefang Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Multi-omics joint analysis reveals that the Miao medicine Yindanxinnaotong formula attenuates non-alcoholic fatty liver disease
Lei Huang, Qing Rao, Chaoyan Wang, et al.
Phytomedicine (2024) Vol. 135, pp. 156026-156026
Closed Access | Times Cited: 3
The science behind TCM and Gut microbiota interaction—their combinatorial approach holds promising therapeutic applications
Wenrui Xia, Bei Liu, Shiyun Tang, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 17
Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
Zhijia Zhou, Jinghao Zhang, Liping You, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 16
JianPi-QingHua formula attenuates nonalcoholic fatty liver disease by regulating the AMPK/SIRT1/NF-κB pathway in high-fat-diet-fed C57BL/6 mice
Jing Tian, Mengjie Cai, Shenyi Jin, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 647-656
Open Access | Times Cited: 9
Compatibility with Semen Sojae Praeparatum attenuates hepatotoxicity of Gardeniae Fructus by regulating the microbiota, promoting butyrate production and activating antioxidant response
Yusha Luo, Xing‐Jie Zhang, Wen Zhang, et al.
Phytomedicine (2021) Vol. 90, pp. 153656-153656
Closed Access | Times Cited: 20
Lian-Mei-Yin formula alleviates diet-induced hepatic steatosis by suppressing Yap1/FOXM1 pathway-dependent lipid synthesis
Peiguang Zhang, Jieqiong Cao, Xujing Liang, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top